Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis

Documenti analoghi

• Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
  di: Osamu Maeda, et al.
  Pubblicazione: (2024)
• Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
  di: Sachiyo Onishi, et al.
  Pubblicazione: (2024)
• Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
  di: Guihong Liu, et al.
  Pubblicazione: (2024)
• Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer
  di: Mary Beth Nierengarten
  Pubblicazione: (2025)
• An ultrasound‐based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation
  di: Qijun Zheng, et al.
  Pubblicazione: (2024)